Accessibility

Read our policy on accessibility for our siteRead more

Clinical Trial Capacity

We’ve invested more than £500,000 to fund vital clinical trial posts at leading centres of excellence in the UKRead more

Duchenne UK and DMD Pathfinders launch campaign for treatments for Adults with DMD

The joint campaign will ensure that treatments and therapies developed are relevant and available to adults living with DMD.Read more

Montelukast: Repurposing of an anti-inflammatory drug to potentially promote muscle strength and movement

Duchenne UK is funding research into montelukast as a potential therapy for Duchenne Muscular DystrophyRead more

Peptide Generation (PepGen) project

Duchenne UK is pleased to announce its support of the development of the next generation of exon skipping drugsRead more

Elastase inhibitors as a potential treatment for DMD

Duchenne UK is co-funding a study into the use of elastase inhibitors to treat the symptoms of Duchenne Muscular Dystrophy (DMD) in partnership with Joining Jack and Charley's Fund.Read more

President & Patrons

HRH The Duchess of CornwallRead more

Gene Therapy Overview

An exciting new gene-based therapy on the horizonRead more

Meet The Team

Our Management teamRead more

Patient Advisory Board

Patient and parent involvement is at the heart of Duchenne UKRead more

Scientific Advisory Board

Our Scientific Advisory Board includes some of the world's leading experts in Duchenne muscular dystrophy.Read more

xmas resources

Read more

water bottle

Read more

january page

Read more

sky

Read more

Patient representation

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Read more